COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,728,564 | 41,904,586 | SH | | SOLE | | 41,904,586 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 2,885 | 25,640 | SH | | SOLE | | 25,640 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 675 | 163,830 | SH | | SOLE | | 163,830 | 0 | 0 |
Adaptive Biotechnologies Corporation | COM | 00650F109 | 21,423 | 440,539 | SH | | SOLE | | 440,539 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 50,516 | 6,330,354 | SH | | SOLE | | 6,330,354 | 0 | 0 |
ADC Therapeutics SA | SHS | H0036K147 | 55,671 | 1,687,500 | SH | | SOLE | | 1,687,500 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 31,051 | 4,379,592 | SH | | SOLE | | 4,379,592 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 643 | 189,800 | SH | | SOLE | | 189,800 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 4,058 | 131,788 | SH | | SOLE | | 131,788 | 0 | 0 |
Albireo Pharma, Inc. | COM | 01345P106 | 18,322 | 549,047 | SH | | SOLE | | 549,047 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 2,798 | 265,600 | SH | | SOLE | | 265,600 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,002,498 | 8,760,794 | SH | | SOLE | | 8,760,794 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 22,519 | 1,359,001 | SH | | SOLE | | 1,359,001 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 56,890 | 698,469 | SH | | SOLE | | 698,469 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 29,132 | 2,206,955 | SH | | SOLE | | 2,206,955 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 134,799 | 32,018,867 | SH | | SOLE | | 32,018,867 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 7,187 | 487,243 | SH | | SOLE | | 487,243 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 27,049 | 896,551 | SH | | SOLE | | 896,551 | 0 | 0 |
Applied Therapeutics, Inc. | COM | 03828A101 | 790 | 38,034 | SH | | SOLE | | 38,034 | 0 | 0 |
Aravive, Inc. | COM | 03890D108 | 357 | 75,854 | SH | | SOLE | | 75,854 | 0 | 0 |
Arcus Biosciences, Inc. | COM | 03969F109 | 1,978 | 115,425 | SH | | SOLE | | 115,425 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 267,654 | 1,019,557 | SH | | SOLE | | 1,019,557 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 546,334 | 3,540,270 | SH | | SOLE | | 3,540,270 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 25,341 | 1,541,418 | SH | | SOLE | | 1,541,418 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 16,288 | 882,352 | SH | | SOLE | | 882,352 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 49,353 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 23,834 | 1,618,029 | SH | | SOLE | | 1,618,029 | 0 | 0 |
Autolus Therapeutics plc | SPONSORED ADS | 05280R100 | 5,370 | 461,324 | SH | | SOLE | | 461,324 | 0 | 0 |
Axsome Therapeutics, Inc. | COM | 05464T104 | 68,383 | 959,757 | SH | | SOLE | | 959,757 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 3,810,109 | 13,301,597 | SH | | SOLE | | 13,301,597 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 1,637 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 43,610 | 12,695,818 | SH | | SOLE | | 12,695,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 577,393 | 7,589,294 | SH | | SOLE | | 7,589,294 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 13,595 | 252,000 | SH | | SOLE | | 252,000 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 5,951 | 237,300 | SH | | SOLE | | 237,300 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 6,898 | 636,363 | SH | | SOLE | | 636,363 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 1,409 | 474,400 | SH | | SOLE | | 474,400 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 85,845 | 13,713,195 | SH | | SOLE | | 13,713,195 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 49,310 | 899,821 | SH | | SOLE | | 899,821 | 0 | 0 |
Chiasma, Inc. | COM | 16706W102 | 3,191 | 742,133 | SH | | SOLE | | 742,133 | 0 | 0 |
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 2,701 | 133,333 | SH | | SOLE | | 133,333 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 4,737 | 302,320 | SH | | SOLE | | 302,320 | 0 | 0 |
Cymabay Therapeutics, Inc. | COM | 23257D103 | 23,548 | 3,252,542 | SH | | SOLE | | 3,252,542 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 25,283 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 3,562 | 99,400 | SH | | SOLE | | 99,400 | 0 | 0 |
Dicerna Pharmaceuticals, Inc. | COM | 253031108 | 2,035 | 113,135 | SH | | SOLE | | 113,135 | 0 | 0 |
Exact Sciences Corporation | COM | 30063P105 | 188,214 | 1,846,139 | SH | | SOLE | | 1,846,139 | 0 | 0 |
Evofem Biosciences, Inc. | COM | 30048L104 | 1,022 | 433,048 | SH | | SOLE | | 433,048 | 0 | 0 |
Frequency Therapeutics, Inc. | COM | 35803L108 | 18,241 | 949,555 | SH | | SOLE | | 949,555 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 88,292 | 1,771,509 | SH | | SOLE | | 1,771,509 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 21,869 | 546,189 | SH | | SOLE | | 546,189 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 1,761 | 12,412 | SH | | SOLE | | 12,412 | 0 | 0 |
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 725 | 205,375 | SH | | SOLE | | 205,375 | 0 | 0 |
Gamida Cell Ltd. | SHS | M47364100 | 2,628 | 633,324 | SH | | SOLE | | 633,324 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 1,194 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Genfit SA | ADS | 372279109 | 150 | 28,396 | SH | | SOLE | | 28,396 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 50,749 | 920,375 | SH | | SOLE | | 920,375 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 13,507 | 138,745 | SH | | SOLE | | 138,745 | 0 | 0 |
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 13,560 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 88,842 | 5,994,704 | SH | | SOLE | | 5,994,704 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 6,634 | 700,481 | SH | | SOLE | | 700,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 51,774 | 666,500 | SH | | SOLE | | 666,500 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 9,863 | 4,608,786 | SH | | SOLE | | 4,608,786 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 232,092 | 3,144,446 | SH | | SOLE | | 3,144,446 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 10,625 | 1,001,414 | SH | | SOLE | | 1,001,414 | 0 | 0 |
Immunomedics, Inc. | COM | 452907108 | 20,211 | 237,694 | SH | | SOLE | | 237,694 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,871,626 | 31,999,398 | SH | | SOLE | | 31,999,398 | 0 | 0 |
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 679 | 580,400 | SH | | SOLE | | 580,400 | 0 | 0 |
Inflarx N.V. | COM | N44821101 | 4,292 | 1,007,559 | SH | | SOLE | | 1,007,559 | 0 | 0 |
Inozyme Pharma, Inc. | COM | 45790W108 | 3,115 | 118,500 | SH | | SOLE | | 118,500 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 73,045 | 2,272,712 | SH | | SOLE | | 2,272,712 | 0 | 0 |
Intellia Therapeutics, Inc. | COM | 45826J105 | 2,430 | 122,238 | SH | | SOLE | | 122,238 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 513,739 | 11,850,962 | SH | | SOLE | | 11,850,962 | 0 | 0 |
Iteos Therapeutics, Inc. | COM | 46565G104 | 4,134 | 167,562 | SH | | SOLE | | 167,562 | 0 | 0 |
IVERIC bio, Inc. | COM | 46583P102 | 7,930 | 1,406,037 | SH | | SOLE | | 1,406,037 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 6,014 | 77,776 | SH | | SOLE | | 77,776 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 2,783 | 574,958 | SH | | SOLE | | 574,958 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 42,890 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 63,302 | 1,959,211 | SH | | SOLE | | 1,959,211 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 731,372 | 12,352,175 | SH | | SOLE | | 12,352,175 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 33,372 | 775,192 | SH | | SOLE | | 775,192 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 1,108 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 3,958 | 128,200 | SH | | SOLE | | 128,200 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 178,002 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 24,450 | 2,037,469 | SH | | SOLE | | 2,037,469 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 234,095 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 10,656 | 553,009 | SH | | SOLE | | 553,009 | 0 | 0 |
Molecular Templates, Inc. | COM | 608550109 | 1,625 | 148,817 | SH | | SOLE | | 148,817 | 0 | 0 |
MyoKardia, Inc. | COM | 62857M105 | 410,264 | 3,009,344 | SH | | SOLE | | 3,009,344 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 45,861 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 65,098 | 676,975 | SH | | SOLE | | 676,975 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 1,879 | 118,100 | SH | | SOLE | | 118,100 | 0 | 0 |
Novavax, Inc. | COM | 670002401 | 20,302 | 187,376 | SH | | SOLE | | 187,376 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 62,451 | 1,788,921 | SH | | SOLE | | 1,788,921 | 0 | 0 |
Orchard Therapeutics plc | ADS | 68570P101 | 1,411 | 343,202 | SH | | SOLE | | 343,202 | 0 | 0 |
Ovid Therapeutics Inc. | COM | 690469101 | 3,391 | 590,761 | SH | | SOLE | | 590,761 | 0 | 0 |
Oyster Point Pharma, Inc. | COM | 69242L106 | 1,440 | 68,228 | SH | | SOLE | | 68,228 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 32,078 | 3,250,000 | SH | | SOLE | | 3,250,000 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 3,423 | 261,066 | SH | | SOLE | | 261,066 | 0 | 0 |
Prelude Therapeutics Incorporated | COM | 74065P101 | 304,875 | 10,118,636 | SH | | SOLE | | 10,118,636 | 0 | 0 |
Protagonist Therapeutics, Inc. | COM | 74366E102 | 31,206 | 1,596,198 | SH | | SOLE | | 1,596,198 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 3,360 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 5,181 | 53,183 | SH | | SOLE | | 53,183 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 4,756 | 206,586 | SH | | SOLE | | 206,586 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 53,550 | 2,471,155 | SH | | SOLE | | 2,471,155 | 0 | 0 |
Sangamo Therapeutics, Inc. | COM | 800677106 | 8,976 | 949,823 | SH | | SOLE | | 949,823 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 9,250,154 | 47,269,424 | SH | | SOLE | | 47,269,424 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 66 | 53,066 | SH | | SOLE | | 53,066 | 0 | 0 |
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 6,101 | 690,167 | SH | | SOLE | | 690,167 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 2,490 | 122,532 | SH | | SOLE | | 122,532 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 7,159 | 194,383 | SH | | SOLE | | 194,383 | 0 | 0 |
Urovant Sciences Ltd. | SHS | G9381B108 | 9,139 | 978,505 | SH | | SOLE | | 978,505 | 0 | 0 |
Vaxart, Inc. | COM | 92243A200 | 10,415 | 1,566,121 | SH | | SOLE | | 1,566,121 | 0 | 0 |
Viking Therapeutics, Inc. | COM | 92686J106 | 2,352 | 404,200 | SH | | SOLE | | 404,200 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 15,909 | 410,142 | SH | | SOLE | | 410,142 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 8,417 | 760,308 | SH | | SOLE | | 760,308 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 79,581 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,650 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
Invitae Corporation | NOTE 2.0% 9/1/2024 | 46185LAB9 | 16,905 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 42,342 | 30,770,000 | PRN | | SOLE | | 30,770,000 | 0 | 0 |